Presented positive updated data from ASPEN-06 Phase 2 trial demonstrating evorpacept generates strong response and durable clinical benefit in ...

CB-010 ANTLER 2L LBCL and CB-011 CaMMouflage r/r MM Phase 1 clinical data expected in H1 2025 ---- Advancing four clinical programs for ...

Coherus BioSciences, Inc. ( NASDAQ: CHRS) Q4 2024 Earnings Conference Call March 10, 2025 5:00 PM ET Jodi Sievers - Head of IR Denny Lanfear - CEO Paul Reider - CCO Sameer Goregaoker - SVP, ...

At the 2025 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium ... including ALX Oncology’s Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and other ...

The results are still preliminary, but Pfizer said that if it hits primary endpoints later this year could form ... its full dose once a week thereafter. J&J also reported new data at ASCO from ...

Dr. Mellar Davis discusses the joint guideline from MASCC, ASCO, AAHPM, HPNA, and NICSO on opioid conversion in adults with cancer. He reviews the limited evidence, and the formal consensus process ...

ASCO Journals have adopted a format-free submission policy (EZSubmit). New submissions are not scrutinized for compliance with our formatting guidelines (reference style, order of components, figure ...

Almee takes the form of a nine-week CBT course that has been ... The Swedish company says it plans to present full results from the COMPANION study at a conference later this year and is looking ...

Though a Full Moon only occurs during the exact moment when Earth, Moon, and Sun form a perfect alignment, to our eyes, the Moon seems Full for around three days. There are a wide variety of ...

A clip being widely shared online, which appears to be a news report covering a moment where the Ukrainian president swore when asked about President Donald Trump, is fake. The clip appears to show ...

The most well-known form of OTT media services is associated with video streaming. Monthly-based or full-scale video subscription services like Netflix paid stores like iTunes, or ad-supported ...